Migraine prophylaxis with topiramate and bone health in women

Headache

Volumn 51, Issue 4, 2011, Pages 613-616

  Ali, Imran I ^a   Herial, Nabeel A ^a   Orris, Megan ^a   Horrigan, Terrance ^a   Tietjen, Gretchen E ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

Antiepileptic drugs; Bone density; Energy x ray absorptiometry scan; Migraine; Topiramate; Vitamin D

Indexed keywords

ANTICONVULSIVE AGENT; OSTEOCALCIN; TOPIRAMATE; VITAMIN D;

ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CLINICAL ARTICLE; FEMALE; HUMAN; MIGRAINE; OSTEOLYSIS; OSTEOPENIA; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; ANTICONVULSANTS; BONE AND BONES; BONE DISEASES, METABOLIC; CROSS-SECTIONAL STUDIES; FEMALE; FRUCTOSE; HUMANS; MIDDLE AGED; MIGRAINE DISORDERS; PILOT PROJECTS; SEX FACTORS;

EID: 79953715965     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01863.x     Document Type: Article

References (14)

1. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349. (Pubitemid 46184209)
2. Vikelis M, Rapoport AM. Role of antiepileptic drugs as preventive agents for migraine.CNS Drugs. 2010;24:21-33.
3. Johannessen Landmark C. Antiepileptic drugs in non-epilepsy disorders: Relations between mechanisms of action and clinical efficacy. CNS Drugs. 2008;22:27-47. (Pubitemid 350243365)
4. Verrotti A, Coppola G, Parisi P, et al. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg. 2010;112:1-10.
5. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9-160.
6. Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: Epidemiology, mechanisms and therapeutic implications. CNS Drugs. 2001;15:633-642. (Pubitemid 32848344)
7. Pack AM, Morrell MJ, Randall A, et al. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy. Neurology. 2008;70:1586-1593. (Pubitemid 351620313)
8. Ensrud KE, Walczak TS, Blackwell T, et al. Antiepileptic drug use increases rates of bone loss in older women: A prospective study. Neurology. 2004;62:2051-2057. (Pubitemid 38738220)
9. Mirza N, Marson AG, Pirmohamed M. Effect of topiramate on acid-base balance: Extent, mechanism and effects. Br J Clin Pharmacol. 2009;68:655-661.
10. Vega D, Maalouf NM, Sakhaee K. Increased propensity for calcium phosphate kidney stones with topiramate use. Expert Opin Drug Saf. 2007;6:547-557. (Pubitemid 351308213)
11. Ali II, Schuh L, Barkley GL, Gates JR. Antiepileptic drugs and reduced bone mineral density. Epilepsy Behav. 2004;5:296-300. (Pubitemid 38950087)
12. Janssen Korea, Ltd. A cross-sectional, comparative, multi-center study to investigate the effect of topiramate monotherapy on markers of bone mineral metabolism and bone mineral density in premenopausal women with epilepsy.[WWW document] URL: http://www.clinicaltrials.gov/ct2/show/NCT01030094 (accessed February 24, 2011).
13. Pack AM, Morrell MJ. Epilepsy and bone health in adults. Epilepsy Behav. 2004;5:S24-S29. (Pubitemid 38404510)
14. Elliott JO. Possible methods for the prevention of bone loss in persons with epilepsy. Expert Rev Neurother. 2009;9:797-812.